Chennai, Oct. 31 -- Highlights: ...

IntelliGenome, Inc., a developer of CRISPR-based molecular diagnostic technologies, today announced an exclusive distribution ...

Co-Diagnostics Inc. CODX said on Tuesday that it moved closer to launching its point-of-care tuberculosis testing technology ...

Among routinely tested Asian American patients, TB test conversion is uncommon, but travel to higher-prevalence countries nearly doubles the odds of it.

People no longer need a TB test before starting risankizumab (Skyrizi®), unless their healthcare professional decides ...

A retrospective Chinese hospital study found Xpert MTB/RIF was the most sensitive single test for tuberculosis in ...

UKHSA reports that 82.3% of people notified with TB in 2025 were born outside the UK, similar to 82% in 2024. This records ...

These findings were generated by the largest-ever study of "pooled" tuberculosis (TB) testing, carried out by Start4All, a partnership led by LSTM with the Stop TB Partnership and research partners in ...

A ten-year Israeli cohort study found that 0.6 percent of screened Ethiopian migrants developed tuberculosis after arrival, ...

More than 40% of restricted dairy herds tested positive for TB antibodies even after reactor cattle had been removed ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...

Google-backed Nexus AI supports faster, offline TB screening, helping clinicians identify patients who need further testing.